gsk201105056k.htm
FORM 6-K
 
 
SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549
 
 
Report of Foreign Issuer
 
 
Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934
 
 
 
For period ending May 2011
 
GlaxoSmithKline plc
(Name of registrant)


 
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)


 
 
Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F


 
 
Form 20-F x     Form 40-F

 
--

 
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.


 
 
Yes      No x
--
 

 
 
 

 
 GlaxoSmithKline plc - Result of AGM
 
GlaxoSmithKline plc (GSK) announces that at its Annual General Meeting today, all resolutions, including those electing and re-electing Board members, were passed by shareholders.
 
GlaxoSmithKline Annual General Meeting Poll Results
 
The following table shows the votes cast for each resolution:
 
Resolution
Total votes for*
%
Total votes against
%
Total votes cast
Votes withheld**
1
Adoption of Financial Statements
3,849,724,841
99.90
3,972,004
0.10
3,853,696,845
4,824,826
2
Approval of the Remuneration Report
3,506,794,850
92.88
268,917,463
7.12
3,775,712,313
82,829,542
3
Election of Simon Dingemans
3,848,384,170
99.88
4,592,054
0.12
3,852,976,224
5,550,786
4
Election of Ms Stacey Cartwright
3,841,823,906
99.71
11,062,363
0.29
3,852,886,269
5,643,742
5
Election of Ms Judy Lewent
3,843,559,263
99.75
9,499,395
0.25
3,853,058,658
5,471,278
6
Re-election of Sir Christopher Gent
3,736,569,130
96.97
116,649,598
3.03
3,853,218,728
5,314,008
7
Re-election of Andrew Witty
3,848,715,490
99.88
4,521,805
0.12
3,853,237,295
5,293,227
8
Re-election of Professor Sir Roy Anderson
3,849,621,453
99.91
3,645,550
0.09
3,853,267,003
5,262,933
9
Re-election of Dr Stephanie Burns
3,845,994,787
99.81
7,252,653
0.19
3,853,247,440
5,282,496
10
Re-election of Larry Culp
3,679,273,731
95.49
173,856,451
4.51
3,853,130,182
5,398,951
11
Re-election of Sir Crispin Davis
3,845,288,843
99.80
7,870,747
0.20
3,853,159,590
5,370,346
12
Re-election of Sir Deryck Maughan
3,618,533,477
93.91
234,597,016
6.09
3,853,130,493
5,409,443
13
Re-election of James Murdoch
3,749,042,808
97.30
103,982,301
2.70
3,853,025,109
5,504,826
14
Re-election of Dr Daniel Podolsky
3,849,525,259
99.91
3,602,607
0.09
3,853,127,866
5,402,070
15
Re-election of Dr Moncef Slaoui
3,848,000,866
99.87
5,004,470
0.13
3,853,005,336
5,225,725
16
Re-election of Tom de Swaan
3,767,791,974
97.78
85,429,903
2.22
3,853,221,877
5,318,058
17
Re-election of Sir Robert Wilson
3,849,258,200
99.90
4,000,688
0.10
3,853,258,888
5,270,983
18
Re-appointment of Auditors
3,772,864,832
99.32
25,647,503
0.68
3,798,512,335
60,025,660
19
Remuneration of Auditors
3,819,410,091
99.67
12,638,825
0.33
3,832,048,916
26,477,992
20
To authorise the company to make donations to political organisations and incur political expenditure
3,758,221,639
97.62
91,644,592
2.38
3,849,866,231
8,636,488
21
Authority to allot shares
3,781,033,581
98.16
70,843,798
1.84
3,851,877,379
6,624,572
22
Disapplication of pre-emption rights***
3,811,196,075
99.00
38,468,694
1.00
3,849,664,769
8,832,253
23
Authority for the Company to purchase its own shares***
3,786,160,872
98.25
67,324,020
1.75
3,853,484,892
5,049,760
24
Exemption from statement of senior statutory auditor's name
3,829,887,610
99.49
19,439,945
0.51
3,849,327,555
9,159,773
25
Reduced notice of a general meeting other than an AGM***
3,549,744,749
92.16
301,776,965
7.84
3,851,521,714
7,016,010
 
Notes:
  *          Includes discretionary votes.
 
 
**        A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.
 
  ***      Indicates Special Resolutions requiring a 75% majority.
 
 
 
 
 
The following table provides further relevant information:
 
 
 
GlaxoSmithKline's
Eleventh AGM
(2011)
 
 
GlaxoSmithKline's
Tenth AGM
(2010)
 
Issued share capital
(excluding Treasury Shares)
5,163,907,153
5,192,489,588
Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares)
74.72%
70.24%
Total shareholder population
155,990
164,450
Total number of proxies lodged
9,886
11,148
% of shareholders who lodged proxies
6.34%
6.78%
Number of shareholders, corporate representatives and proxies who attended the AGM
364
325
 
V A Whyte
Company Secretary
5 May 2011
 
These results will shortly be available on the Company's website www.gsk.com.
 
Enquiries:
 
GlaxoSmithKline Enquiries:
    
UK Media enquiries:
David Mawdsley
(020) 8047 5502
 
Claire Brough
(020) 8047 5502
 
Stephen Rea
(020) 8047 5502
 
Alexandra Harrison
(020) 8047 5502
 
David Daley
(020) 8047 5502
     
US Media enquiries:
Nancy Pekarek
(919) 483 2839
 
Mary Anne Rhyne
(919) 483 2839
 
Kevin Colgan
(919) 483 2839
 
Jennifer Armstrong
(919) 483 2839
     
European Analyst/Investor enquiries:
Sally Ferguson
(020) 8047 5543
 
Gary Davies
(020) 8047 5503
 
Ziba Shamsi
(020) 8047 3289
     
US Analyst/ Investor enquiries:
Tom Curry
(215) 751 5419
 
Jeff McLaughlin
(215) 751 4890
 
 
 


 
 
 


 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.



 
 
GlaxoSmithKline plc
(Registrant)


Date: May 5, 2011 
 
 
By: VICTORIA WHYTE
------------------
 
 
Victoria Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc